Key result
This review examines the available clinical trials evaluating the use of organic nitrates in acute and chronic heart failure, with no specific quantitative results reported in the abstract.
Why the study?
When should organic nitrates be used in acute and chronic heart failure?
When should organic nitrates be used in acute and chronic heart failure?
This review examines the clinical trials evaluating the use of organic nitrates in acute and chronic heart failure.
No new quantitative guidance on nitrates in HF; leaves open optimal timing and selection for future trials.
Organic nitrates remain among the oldest and most commonly employed drugs in cardiology. Although, in most cases, their use in acute and chronic heart failure is based on clinical practice, only a few clinical trials have been conducted to evaluate their use in acute and chronic heart failure, most of which compare them with other drugs to evaluate differing endpoints. The purpose of this review is to examine the various trials that have evaluated the use of nitrates in acute and chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Vizzardi et al. (2012) conducted a review in Acute and chronic heart failure. Organic nitrates was evaluated. This review examines the available clinical trials evaluating the use of organic nitrates in acute and chronic heart failure, with no specific quantitative results reported in the abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: